Furo[3,2-h]quinoline derivatives were synthesized as a gastric H + /K + -ATPase inhibitors. The oxycyclization of 7 and 8-positions in quinoline potentiated the inhibitory activity, while no significant changes in biological activity were observed by the variation of substituents in furan ring. The several furo[3,2-h]quinoline derivatives were worthy of in vivo investigation for their anti-secretory and anti-ulcer activity.
Introduction
The presence of acid is a fundamental factor in the pathogenesis of gastric and duodenal ulcers, reflux esogastritis, and nonsteroidal antiinflammatory drug-induced lesions. 1 Therefore, it is mandatory to control acid secretion for treatment of these diseases. While acid secretion by parietal cells is regulated through several stimulatory receptors such as histamine H 2 -receptor, muscarine receptor and gastrin receptor, the final step of acid secretion is mediated by the gastric H + /K + -ATPase, so-called proton pump.
2 Proton pump inhibitors have been expected to have potential clinical advantage over histamine H 2 receptor antagonists, because acid secretion is inhibited irrespective of the stimulus. 3 The substituted benzimidazole derivatives irreversibly suppress gastric H + /K + -ATPase, resulting in a long-lasting and potent antisecretory effect. 4, 5 Although these derivatives exert superior healing of acid-related disorders compared to histamine H 2 receptor antagonists, long-term treatment with omeprazole causes bacterial overgrowth in the upper gut due to profound long-standing acid suppression. 6 Sustained acid inhibition due to a long-term treatment with acid inhibitors also induces hypergastrinemia, resulting in the development of gastric enterochromaffin-like (ECL) cell carcinoids in rat 7 and a slight hyperplasia of ECL cells in humans. 8 Recently, many research groups have been interested in the development of reversible gastric H + /K + -ATPase inhibitors to overcome the potential side effects of irreversible proton pump inhibitors. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In quinoline compounds, formation of hydrogen-bonding between the 3-substituted carbonyl oxygen and the 4-arylamine was important factor in maintaining good biological activity. 10 In contrast to restricted 3,4-substituents in quinoline compounds, the 8-position of the quinoline ring tolerated variety of substitutents in maintaining biological activities. In this report, we were particularly interested in biological activity of furo[3,2-h]quinoline derivatives in attempt to find new development candidates.
Experimental Section
The 1 H NMR spectra were obtained on a Varian Gemini 200 MHz NMR Spectrometer. The GC-MS spectra were obtained on a Shimazu QP 1000 GC/MS. Melting points were determined on MUL-TEM apparatus and were uncorrected. All chemicals were used directly as obtained from commercial sources unless otherwise noted. The H + /K + -ATPase-inhibitory and gastric antisecretory activity were tested by the reported methods. 2-Allyl-6-nitrophenol (5.87 g, 32.8 mmol) was dissolved in 100 mL of dichloromethane and anhydrous AlCl3 (4.36 g, 32.8 mmol) was slowly added with stirring. The reaction mixture was allowed to react for 0.5 h at room temperature. Precooled 100 mL of 10% sodium hydroxide solution was slowly added to the reaction mixture with ice cooling. The resulting product was extracted with two 250-mL portions of diethyl ether. The ethereal layer was dried over anhydrous 
. 7-Amino-2-methyl-2,3-dihydrobenzofuran (5). 2-Methyl-7-nitro-2,3-dihydrobenzofuran (3.01 g, 16.8 mmol) was dissolved in 100 mL of absolute methanol. After addition of 5% Pd/C (2.0 g) and HCONH 4 (5.0 g) to the reaction mixture, the resulting mixture was stirred for 20 h at room temperature. The solution was filtered and concentrated. The residue was dissolved in 50 mL of diethyl ether and washed with H 2 O (50 mL). The ethereal layer was dried over MgSO 4 , filtered off, and concentrated. The 7-amino-2-methyl-2,3-dihydrobenzo[b]furan was obtained in 80% yield after silica gel column chromatography: General Procedure for the preparation of 2-acyl-3-alkoxyacrylates (6) and 2-acyl-3-arylaminoacrylate esters (7). A mixture of the β-keto ester (1 equiv), trimethyl orthoformate (2 equiv), and acetic anhydride (1 equiv) was heated at reflux for the appropriate time, and then the volatile components were removed in vacuo (typically 90 o C/0.3 mmHg). The residual liquid consisted largely of the 2-acyl-3-alkoxyacrylates 6 as a mixture of E/Z isomers. The compound 6 was mixed with the appropriate aniline (1 equiv), warmed on a steam bath for 10 min, and then poured into petroleum ether with vigorous stirring. The product was filtered off and washed with ether to give compound 7, usually as a mixture of E/Z isomers. In some cases, a substantial second crop could be recovered from the mother liquors after acid wash to remove unreacted aniline. 
1-[2-Methyl-6-(2-methylphenylamino)-2,3-dihydrofuro-[3,2-h]quinoline-7-yl]butane-1-one (10a)
. 7-Butyryl-2-methyl-3,9-dihydro-2H-furo[3,2-h]quinoline-6-yl methanesulfonate (0.2 g, 0.57 mmol) and 2-methylaniline (0.12 g, 1.1 mmol) was dissolved in 10 mL of acetonitrile and the resulting solution was refluxed for 1 h. The resulting mixture was concentrated and the residue was dissolved in 10 mL of ethyl acetate. The organic solution was washed with aqueous NaHCO 3 , dried over anhydrous MgSO 4 , filtered off and then evaporated. The thermal [3, 3] -sigmatrophic rearrangement of compound 1a gave 2-allyl-6-nitrophenol 2 in 70% yield. Addition of 1.0 equivalent of AlCl 3 to compound 2 at room temperature provided a mixture of compound 3 and 4 in a ratio of 9:1. The treatment of mixture of compound 3 and 4 with aqueous sodium hydroxide gave 7-nitro-2,3-dihydrobenzo[b]furan in 90-97% yield. 20 Although the formation of 5 or 6-membered ring in Claisen rearrangements of phenyl propargyl ethers was quiet dependent upon the nature of substituents on phenyl ring, 21 only aromatized 7-nitrobenzo[b]furan (4) has been achieved by the thermal Claisen rearrangement of compound 1b and sequential cyclization in PEG-200 as a solvent at 220 o C in 63% yield. The nitro group of compound 4 was easily reduced to amino compound 5 under hot Fe/HCl conditions in quantitative yield. Reaction of the appropriately substituted β-keto ester with a trialkyl orthoformate gave compound 6 as a mixture of E and Z isomers. Further reaction of compound 6 with aminobenzofuran gave the acyclic precursor 7. The high temperature cyclization of compound 7 in diphenyl ether gave the quinoline 8, which could be chlorinated with phosphorous oxychloride or mesylated with methanesulfonyl chloride to give compound 9. Subsequent displacement reaction of compound 9 with arylamines gave compound 10 in high yields.
Biological Activity
In the previous report, small variation of ortho substitution of the arylamino group showed a significant change in the biological activity. It was assumed that the twisting aryl ring further out of the plane of the quinoline potentiated the biological activity. Our study was focused on the variation of substituent in the arylamino group. Although 2-methoxy-3-pyridyl instead of 2-methylphenyl group gave similar activity to 2-methylphenyl group (10e), o-methoxy substituents showed low gastric inhibition activity (10b). Addition of hydroxy group or elimination of methyl group from 2-methylphenyl was also unfavorable (10c, d). We also examined the size of 3-substituent for achieving high potency, 1-propanone group also retained good IC 50 value with various aryl substituents (10f-h). On the other hand, aromatized benzofuran derivatives were examined with three different 3-acyl substituents (10i-10q). The different acyl substituents showed similar gastric inhibition effect with various 4-aryl substituents. Finally, dimethylhydrofuran fused quinoline derivatives which were substituted with 2-substituted phenyl or pyridine (10r-10t) were examined. The compound containing trifluoromethylphenyl instead of methylphenyl exhibited similar IC 50 value. The effect of quinoline 3-acyl substituents indicates that neither electron-withdrawing ability nor hydrogenbonding potential alone is sufficient for imparting high activity. Although there may be some direct effect of this group on binding ability to the enzyme, it is also likely that this reflects the critical nature of the precise geometry achieved in the syn-5 form. Modifications of substituents of furan in 7,8-position of the quinoline tolerated good in vitro biological potency.
Conclusions
The present results show that introduction of furan ring to quinoline potentiated the inhibitory activity of the compounds, while no significant biological activity changes were observed by variations of substituents of furan moiety. We observed that modifications of substituent of aryl group also retained in vitro potency. 
